3-METHYL-6-(2-(4-(3-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)ACETYL)-2,3-DIHYDRO-1,3-BENZOXAZOL-2-ONE
UNII A7WB2CD3R9
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-methyl-6-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)acetyl)-2,3-dihydro-1,3-benzoxazol-2-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A7WB2CD3R9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 82608-05-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H20F3N3O3 XERIIBQQYDXGKO-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-methyl-6-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)acetyl)-2,3-dihydro-1,3-benzoxazol-2-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.